Join
Live feed
·
INSIDERFilingvia Quantisnow
Lexeo Therapeutics Inc. logo

Chief Financial Officer Tamayo Louis Edward was granted 12,000 shares and sold $20,838 worth of shares (4,641 units at $4.49), increasing direct ownership by 8% to 97,024 units (SEC Form 4) to cover taxes

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LXEO (Lexeo Therapeutics Inc.) and more on Quantisnow.